Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 19, Issue 5, Pages 768-778
Publisher
Springer Nature
Online
2011-11-25
DOI
10.1038/cdd.2011.170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2Checkpoint and Inhibition of Homologous Recombinational DNA Repair
- (2010) Meredith A. Morgan et al. CANCER RESEARCH
- Targeting the checkpoint kinase Chk1 in cancer therapy
- (2010) Callie Merry et al. CELL CYCLE
- In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
- (2010) J. B. Mitchell et al. CLINICAL CANCER RESEARCH
- New models for cancer research: human cancer stem cell xenografts
- (2010) Marta Baiocchi et al. CURRENT OPINION IN PHARMACOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival
- (2009) Katherine R. Birchard et al. CANCER
- A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics
- (2009) Y. WANG et al. NEOPLASMA
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- Apoptosis and non-apoptotic deaths in cancer development and treatment response
- (2008) Elza C. de Bruin et al. CANCER TREATMENT REVIEWS
- Keeping checkpoint kinases in line: new selective inhibitors in clinical trials
- (2008) Susan Ashwell et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials
- (2008) Guo-Ming Shi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials
- (2008) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
- (2008) S. D. Zabludoff et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now